Evidence map›Paper›PMID 20237158›Full record

ArticleMolecular biology of the cell2010

Endogenous RhoG is rapidly activated after epidermal growth factor stimulation through multiple guanine-nucleotide exchange factors.

Thomas Samson, Christopher Welch, Elizabeth Monaghan-Benson, Klaus M Hahn, Keith Burridge

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Cellular Regulation of Macropinocytosis.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. A Rac1-independent role for P-Rex1 in melanoblasts.The Journal of investigative dermatology · 2015
    Article
  13. Small Rho GTPases in the control of cell shape and mobility.Cellular and molecular life sciences : CMLS · 2014
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Thomas SamsonDepartment of Cell and Developmental Biology, Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
Christopher Welch
Elizabeth Monaghan-Benson
Klaus M Hahn
Keith Burridge
Segeberger Kliniken · DEUniversity of North Carolina at Chapel Hill · USUNC Lineberger Comprehensive Cancer Center

Funding

STRUCTURE/FUNCTION OF FOCAL ADHESIONSR01GM029860 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BURRIDGE, KEITH · 1985 to 2018
$6.7M
The Platelet-Leukocyte Switch in Vascular DiseaseP01HL080166 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JACOBSON, KENNETH A · 2006 to 2010
$6.7M
FLUORESCENT INDICATORS OF RHO AND RAN NUCLEOTIDE STATER01GM057464 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAHN, KLAUS M. · 1999 to 2011
$3.5M
Leukocyte Transendothelial Migration: Coordination of Rho GTPase SignalingF30HL094020 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WELCH, CHRISTOPHER M · 2008 to 2012
$151k
Evolutionary Genomics of Supersized Mitochondrial GenomesF32GM080079 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI ALVERSON, ANDREW J · 2007 to 2009
$148k
FLUORESCENT INDICATORS OF RHO AND RAN NUCLEOTIDE STATER55GM057464 · NIGMS · SCRIPPS RESEARCH INSTITUTE · PI HAHN, KLAUS MICHAEL · 1998 to 1998
–
NHLBI NIH HHS F30 HL094020NHLBI NIH HHS F30HL094020-02NHLBI NIH HHS HL-080166NHLBI NIH HHS P01 HL080166NIGMS NIH HHS F32 GM080079NIGMS NIH HHS GM-029860NIGMS NIH HHS GM-057464NIGMS NIH HHS R01 GM029860NIGMS NIH HHS R01 GM057464NIGMS NIH HHS T32-GM-80079
6 · The paper itself

Abstract

RhoG is a member of the Rac-like subgroup of Rho GTPases and has been linked to a variety of different cellular functions. Nevertheless, many aspects of RhoG upstream and downstream signaling remain unclear; in particular, few extracellular stimuli that modulate RhoG activity have been identified. Here, we describe that stimulation of epithelial cells with epidermal growth factor leads to strong and rapid activation of RhoG. Importantly, this rapid activation was not observed with other growth factors tested. The kinetics of RhoG activation after epidermal growth factor (EGF) stimulation parallel the previously described Rac1 activation. However, we show that both GTPases are activated independently of one another. Kinase inhibition studies indicate that the rapid activation of RhoG and Rac1 after EGF treatment requires the activity of the EGF receptor kinase, but neither phosphatidylinositol 3-kinase nor Src kinases. By using nucleotide-free RhoG pull-down assays and small interfering RNA-mediated knockdown studies, we further show that guanine-nucleotide exchange factors (GEFs) of the Vav family mediate EGF-induced rapid activation of RhoG. In addition, we found that in certain cell types the recently described RhoG GEF PLEKHG6 can also contribute to the rapid activation of RhoG after EGF stimulation. Finally, we present results that show that RhoG has functions in EGF-stimulated cell migration and in regulating EGF receptor internalization.

Indexed as

AnimalsBlotting, WesternCell LineCell Line, TumorCell MovementEndocytosisEpidermal Growth FactorErbB ReceptorsGuanine Nucleotide Exchange FactorsHeLa CellsHumansMiceNIH 3T3 CellsPhosphorylationPlatelet-Derived Growth Factorrac1 GTP-Binding ProteinEpidermal Growth FactorErbB ReceptorsGuanine Nucleotide Exchange FactorsPlatelet-Derived Growth FactorPLEKHG6 protein, humanrac1 GTP-Binding ProteinRHOG protein, humanrho GTP-Binding ProteinsVascular Endothelial Growth Factor A

Identifiers

PMID20237158
PMCPMC2861620
OpenAlexW2149278857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.